US Stock MarketDetailed Quotes

AstraZeneca (AZN)

Watchlist
  • 184.540
  • +2.680+1.47%
Close May 12 16:00 ET
  • 184.540
  • 0.0000.00%
Post 20:01 ET
286.19BMarket Cap27.79P/E (TTM)

AstraZeneca (AZN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
12.51%15.29B
8.63%58.74B
4.11%15.5B
11.99%15.19B
11.74%14.46B
7.17%13.59B
18.03%54.07B
23.84%14.89B
18.04%13.57B
13.33%12.94B
Operating revenue
12.51%15.29B
8.63%58.74B
4.11%15.5B
11.99%15.19B
11.74%14.46B
7.17%13.59B
18.03%54.07B
23.84%14.89B
18.04%13.57B
13.33%12.94B
Cost of revenue
19.50%2.68B
4.17%10.63B
14.42%3.12B
-9.09%2.8B
13.28%2.47B
1.04%2.24B
23.45%10.21B
18.07%2.73B
47.06%3.08B
11.38%2.18B
Gross profit
11.13%12.61B
9.67%48.11B
1.80%12.39B
18.18%12.39B
11.43%11.98B
8.47%11.35B
16.84%43.87B
25.22%12.17B
11.57%10.48B
13.74%10.76B
Operating expense
9.01%8.36B
3.46%34.78B
-7.14%9.41B
5.12%8.81B
5.83%8.48B
4.45%7.67B
16.63%33.62B
19.43%10.13B
12.56%8.38B
14.41%8.01B
Selling and administrative expenses
9.38%5.06B
2.72%20.77B
1.66%5.65B
-1.04%5.23B
-1.07%5.01B
-0.06%4.63B
10.99%20.22B
0.67%5.55B
7.28%5.29B
-1.09%5.06B
-Selling and marketing expense
4.44%141M
4.32%579M
6.99%153M
2.07%148M
8.33%143M
0.00%135M
2.97%555M
-1.38%143M
12.40%145M
0.76%132M
-General and administrative expense
9.53%4.92B
2.67%20.2B
1.52%5.49B
-1.13%5.09B
-1.32%4.86B
-0.07%4.49B
11.23%19.67B
0.73%5.41B
7.15%5.14B
-1.14%4.93B
Research and development costs
10.54%3.49B
4.78%14.23B
-17.43%3.86B
17.59%3.66B
17.95%3.55B
13.51%3.16B
24.22%13.58B
52.20%4.68B
20.55%3.12B
12.79%3.01B
Other operating expenses
----
10.74%134M
----
-256.00%-89M
-31.67%-79M
----
-26.22%121M
---100M
---25M
---60M
Operating profit
15.57%4.25B
30.01%13.33B
46.27%2.98B
70.13%3.58B
27.75%3.51B
17.95%3.67B
17.53%10.25B
64.99%2.04B
7.78%2.11B
11.81%2.75B
Net non-operating interest income expense
-20.75%-320M
6.21%-1.25B
4.38%-349M
-27.37%-349M
-8.16%-371M
12.25%-265M
-3.80%-1.34B
-8.31%-365M
5.84%-274M
6.54%-343M
Non-operating interest income
-13.10%73M
4.35%360M
110.94%135M
-53.55%85M
-32.00%68M
-24.32%84M
14.62%345M
-40.74%64M
81.19%183M
56.25%100M
Non-operating interest expense
12.61%393M
-4.04%1.61B
12.82%484M
-5.03%434M
-0.90%439M
-15.50%349M
5.85%1.68B
-3.60%429M
16.58%457M
2.78%443M
Other net income (expense)
Special income (charges)
----
267.74%416M
----
----
----
----
53.12%-248M
----
----
----
-Less:Restructuring and merger&acquisition
----
-116.92%-44M
----
----
----
----
-50.00%260M
----
----
----
-Less:Other special charges
----
-3,000.00%-372M
----
----
----
----
-233.33%-12M
----
----
----
Income before tax
15.05%3.91B
42.70%12.4B
57.80%2.63B
77.46%3.24B
30.45%3.13B
21.50%3.4B
25.97%8.69B
85.73%1.67B
10.65%1.83B
14.80%2.4B
Income tax
73.18%833M
31.45%2.17B
80.72%300M
79.49%709M
44.78%679M
-22.42%481M
75.91%1.65B
367.74%166M
44.16%395M
75.00%469M
Net income
5.48%3.08B
45.33%10.23B
55.27%2.33B
76.90%2.54B
26.97%2.45B
33.99%2.92B
18.12%7.04B
56.41%1.5B
3.99%1.43B
5.93%1.93B
Net income continuous Operations
5.48%3.08B
45.33%10.23B
55.27%2.33B
76.90%2.54B
26.97%2.45B
33.99%2.92B
18.12%7.04B
56.41%1.5B
3.99%1.43B
5.93%1.93B
Minority interest income
-80.00%1M
33.33%8M
3M
-50.00%2M
-300.00%-2M
400.00%5M
0.00%6M
0
0.00%4M
-50.00%1M
Net income attributable to the parent company
5.62%3.08B
45.34%10.23B
55.07%2.33B
77.26%2.53B
27.14%2.45B
33.82%2.92B
18.14%7.04B
56.25%1.5B
4.00%1.43B
6.00%1.93B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
5.62%3.08B
45.34%10.23B
55.07%2.33B
77.26%2.53B
27.14%2.45B
33.82%2.92B
18.14%7.04B
56.25%1.5B
4.00%1.43B
6.00%1.93B
Basic earnings per share
5.85%1.99
45.37%6.6
54.64%1.5
78.26%1.64
27.42%1.58
33.33%1.88
18.23%4.54
56.45%0.97
3.37%0.92
5.98%1.24
Diluted earnings per share
5.35%1.97
45.33%6.54
55.21%1.49
78.02%1.62
26.61%1.57
33.57%1.87
18.11%4.5
54.84%0.96
3.41%0.91
5.98%1.24
Dividend per share
1.61%2.1504
4.66%3.1331
0
-0.20%1.0167
0
7.17%2.1164
4.09%2.9937
0
11.64%1.0188
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 12.51%15.29B8.63%58.74B4.11%15.5B11.99%15.19B11.74%14.46B7.17%13.59B18.03%54.07B23.84%14.89B18.04%13.57B13.33%12.94B
Operating revenue 12.51%15.29B8.63%58.74B4.11%15.5B11.99%15.19B11.74%14.46B7.17%13.59B18.03%54.07B23.84%14.89B18.04%13.57B13.33%12.94B
Cost of revenue 19.50%2.68B4.17%10.63B14.42%3.12B-9.09%2.8B13.28%2.47B1.04%2.24B23.45%10.21B18.07%2.73B47.06%3.08B11.38%2.18B
Gross profit 11.13%12.61B9.67%48.11B1.80%12.39B18.18%12.39B11.43%11.98B8.47%11.35B16.84%43.87B25.22%12.17B11.57%10.48B13.74%10.76B
Operating expense 9.01%8.36B3.46%34.78B-7.14%9.41B5.12%8.81B5.83%8.48B4.45%7.67B16.63%33.62B19.43%10.13B12.56%8.38B14.41%8.01B
Selling and administrative expenses 9.38%5.06B2.72%20.77B1.66%5.65B-1.04%5.23B-1.07%5.01B-0.06%4.63B10.99%20.22B0.67%5.55B7.28%5.29B-1.09%5.06B
-Selling and marketing expense 4.44%141M4.32%579M6.99%153M2.07%148M8.33%143M0.00%135M2.97%555M-1.38%143M12.40%145M0.76%132M
-General and administrative expense 9.53%4.92B2.67%20.2B1.52%5.49B-1.13%5.09B-1.32%4.86B-0.07%4.49B11.23%19.67B0.73%5.41B7.15%5.14B-1.14%4.93B
Research and development costs 10.54%3.49B4.78%14.23B-17.43%3.86B17.59%3.66B17.95%3.55B13.51%3.16B24.22%13.58B52.20%4.68B20.55%3.12B12.79%3.01B
Other operating expenses ----10.74%134M-----256.00%-89M-31.67%-79M-----26.22%121M---100M---25M---60M
Operating profit 15.57%4.25B30.01%13.33B46.27%2.98B70.13%3.58B27.75%3.51B17.95%3.67B17.53%10.25B64.99%2.04B7.78%2.11B11.81%2.75B
Net non-operating interest income expense -20.75%-320M6.21%-1.25B4.38%-349M-27.37%-349M-8.16%-371M12.25%-265M-3.80%-1.34B-8.31%-365M5.84%-274M6.54%-343M
Non-operating interest income -13.10%73M4.35%360M110.94%135M-53.55%85M-32.00%68M-24.32%84M14.62%345M-40.74%64M81.19%183M56.25%100M
Non-operating interest expense 12.61%393M-4.04%1.61B12.82%484M-5.03%434M-0.90%439M-15.50%349M5.85%1.68B-3.60%429M16.58%457M2.78%443M
Other net income (expense)
Special income (charges) ----267.74%416M----------------53.12%-248M------------
-Less:Restructuring and merger&acquisition -----116.92%-44M-----------------50.00%260M------------
-Less:Other special charges -----3,000.00%-372M-----------------233.33%-12M------------
Income before tax 15.05%3.91B42.70%12.4B57.80%2.63B77.46%3.24B30.45%3.13B21.50%3.4B25.97%8.69B85.73%1.67B10.65%1.83B14.80%2.4B
Income tax 73.18%833M31.45%2.17B80.72%300M79.49%709M44.78%679M-22.42%481M75.91%1.65B367.74%166M44.16%395M75.00%469M
Net income 5.48%3.08B45.33%10.23B55.27%2.33B76.90%2.54B26.97%2.45B33.99%2.92B18.12%7.04B56.41%1.5B3.99%1.43B5.93%1.93B
Net income continuous Operations 5.48%3.08B45.33%10.23B55.27%2.33B76.90%2.54B26.97%2.45B33.99%2.92B18.12%7.04B56.41%1.5B3.99%1.43B5.93%1.93B
Minority interest income -80.00%1M33.33%8M3M-50.00%2M-300.00%-2M400.00%5M0.00%6M00.00%4M-50.00%1M
Net income attributable to the parent company 5.62%3.08B45.34%10.23B55.07%2.33B77.26%2.53B27.14%2.45B33.82%2.92B18.14%7.04B56.25%1.5B4.00%1.43B6.00%1.93B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 5.62%3.08B45.34%10.23B55.07%2.33B77.26%2.53B27.14%2.45B33.82%2.92B18.14%7.04B56.25%1.5B4.00%1.43B6.00%1.93B
Basic earnings per share 5.85%1.9945.37%6.654.64%1.578.26%1.6427.42%1.5833.33%1.8818.23%4.5456.45%0.973.37%0.925.98%1.24
Diluted earnings per share 5.35%1.9745.33%6.5455.21%1.4978.02%1.6226.61%1.5733.57%1.8718.11%4.554.84%0.963.41%0.915.98%1.24
Dividend per share 1.61%2.15044.66%3.13310-0.20%1.016707.17%2.11644.09%2.9937011.64%1.01880
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions --Unqualified Opinion----------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More